Skip to main content
. 2018 Dec 17;42(3):zsy256. doi: 10.1093/sleep/zsy256

Table 1.

Subject characteristics

Healthy sleepers (N = 19) OSA
Chronic OSA (diagnostic) (N = 28) Treated OSA(CPAP)(N = 28) Acute OSA(CPAP withdrawal)(N = 24)
Demographics
 Age (years) 33.7 ± 1.6 47.3 ± 11.3a 48.5 ± 2.2a
 Sex 12M/7F 21M/7F 17M/7F
 BMI 25.6 ± 1.1 37.9 ± 1.6a 37.7 ± 1.6a
 AHI3A (/hour) 4.5 ± 3.5 67.9 ± 5.4a 5.4 ± 0.7b 59.3 ± 4.5a,c
 Arousal index (/hour) 13.3 ± 1.3 48.6 ± 4.9a 12.0 ± 1.2b 36.4 ± 4.9a,c
 Adherence (hour) 4.9 ± 1.7
Sleep architecture
 TST (min) 440.4 ± 18.3 426.5 ± 14.3 445.84 ± 11.5 423.8 ± 8.3
 WASO (%) 6.8 (5.1) 15.2 (13.5)a 10.1 (7.1) 13.2 (7.3)a
 SE (%) 88.5 (6.7) 83.1 (12.5) 88.4 (8.1) 86.6 (8.8)
 Stage N1 (%) 16.6 ± 1.2 41.4 ± 3.2a 12.7 ± 0.9b 35.7 ± 2.7c,a
 Stage N2 (%) 49.1 ± 2.0 37.2 ± 2.6a 48.9 ± 1.9b 44.8 ± 2.0
 SWS (%) 9.1 (8.1) 4.2 (13.1) 13.1 (8.4)b 2.1 (6.3)c
 REM (%) 19.2 ± 1.2 14.8 ± 1.3a 21.5 ± 1.1b 12.4 ± 1.3a,c
Daytime sleepiness
 PVT Lapses 1.7 (1.5) 6.1 (7.1)a 3.7 (2.3)a,b 6.5 (7.9)a,c
 ESS 5.2 ± 0.5 13.0 ± 1.0a 10.7 ± 1.0a
 Mean MSLT (minute) 10.5 ± 1.1 5.5 ± 0.6a 7.2 ± 0.6a,b 5.5 ± 0.6a,c

Normally distributed variables are reported as mean ± SD, whereas non-normally distributed variables are reported as median (interquartile range). SE, sleep efficiency; SWS, slow-wave sleep.

aCompared to healthy sleepers (p < 0.05).

bCompared to chronic OSA (p < 0.05).

cCompared to treated OSA (p < 0.05).